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A B S T R A C T
Neuroligins are synaptic adhesion molecules and important determinants of synaptic function. They are
expressed at postsynaptic sites and involved in synaptic organization through key extracellular and in-
tracellular protein interactions. They undergo trans-synaptic interactionwith presynaptic neurexins. Distinct
neuroligins use differences in their intracellular domains to selectively recruit synaptic scaffolds and this
plays an important role in how they encode specialization of synaptic function. Several levels of regu-
lation including gene expression, splicing, protein translation and processing regulate the expression of
neuroligin function. We have used in silico and cDNA analyses to investigate the mRNA splicing of the
Caenorhabditis elegans orthologue nlg-1. Transcript analysis highlights the potential for gene regulation
with respect to both temporal expression and splicing. We found nlg-1 splice variants with all the pre-
dicted exons are a minor species relative to major splice variants lacking exons 13 and 14, or 14 alone.
These major alternatively spliced variants change the intracellular domain of the gene product NLG-1.
Interestingly, exon 14 encodes a cassette with two distinct potential functional domains. One is a polyproline
SH3 binding domain and the other has homology to a region encoding the binding site for the scaffold-
ing protein gephyrin in mammalian neuroligins. This suggests differential splicing impacts on NLG-1
competence to recruit intracellular binding partners. This may have developmental relevance as nlg-1
exon 14 containing transcripts are selectively expressed in L2–L3 larvae. These results highlight a de-
velopmental regulation of C. elegans nlg-1 that could play a key role in the assembly of synaptic protein
complexes during the early stages of nervous system development.
© 2015 Elsevier B.V. All rights reserved.
Intercellular communication between neurons is mediated by
the alignment of pre and postsynaptic elements. This involves trans-
synaptic interactions between cell surface molecules and selective
recruitment of signalling scaffolds through the intracellular domains
of such adhesion molecules. The molecular architecture generates
a synaptic ‘code’, in which different classes of cell-type-speciﬁc
contact molecules drive the maturation, stabilization and signal-
ling of synapses. An important class of the synaptic adhesion proteins
that help deﬁne the synaptic code are the neuroligins (Yamagata
et al., 2003).
Five neuroligin genes exist in human (NLGN-1, -2, -3, -4X, -4Y)
and they are expressed in different neuronal classes (Budreck and
Scheiffele, 2007; Ichtchenko et al., 1996). They interact with the cell
adhesion proteins, the neurexins, and other ligands at the synapse
(Bourne and Marchot, 2014) producing interactions that contrib-
ute to differentiation, plasticity and speciﬁcity of synapses (Craig
and Kang, 2007; Dean and Dresbach, 2006; Varoqueaux et al., 2004).
Rare variants in the human genes encoding postsynaptic neuroligin-3
and 4 (NLGN-3 and -4), and their presynaptic binding partner
neurexin-1 (NRXN-1) have been linked with autism spectrum dis-
orders (ASD) (Sudhof, 2008). The human neurexin and neuroligin
genes are orthologous to the Caenorhabditis elegans genes nrx-1 and
nlg-1, respectively (Calahorro, 2014).
nlg-1 is expressed throughout the nervous system of C. elegans
and the NLG-1 protein is located at postsynaptic sites of the body
wall muscle, although it is also expressed presynaptically in some
neurons (Feinberg et al., 2008). NLG-1 from C. elegans and the mam-
malian neuroligins present signiﬁcant homology in terms of their
amino acid sequences. Neuroligin in both human and the nema-
tode harbour the same functional domains encompassing an
extracellular cholinesterase-like domain, a type-1 transmem-
brane sequence and a short intracellular domain ending in a
PDZ-binding motif (Calahorro and Ruiz-Rubio, 2012).
Cell type-speciﬁc gene expression programs lead to huge diver-
sity in neuronal properties. Furthermore, alternative splicing greatly
ampliﬁes the coding capacity of the genome, providing a powerful
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mechanism to control functional diversity. Splicing is particularly
well detailed for the neurexin gene family where both cell and
isoform speciﬁc splicing occur. This capacity is enhanced by activity-
dependent alternative splicing which broadly acts to mediate
dynamic modiﬁcation of neuronal function (Treutlein et al., 2014).
This generates speciﬁc splice variants modifying the signalling prop-
erties or the function of synaptic proteins (An and Grabowski, 2007;
Li et al., 2007). The splicing patterns of neuroligins are less well char-
acterized than neurexin. However, the gene organization suggests
there is a splice regulation of their trans-synaptic signalling poten-
tial (Lee et al., 2010).
The reported splicing of mammalian neuroligins show they are
differentially spliced at one position (splice site A, SSA) in exon 2
or 3 that encodes the beginning of the extracellular domains. Ad-
ditionally, NLGN-1 presents another splice position (splice site B, SSB)
in exon 5 that encodes the central region of the acetylcholinester-
ase domain (Calahorro, 2014; Ichtchenko et al., 1995, 1996).
Functional impact of these differences is indicated by in vitro ob-
servations that NLGN-1 lacking SSB induce a rapid presynaptic
differentiation of approaching neurons relative to the full length
NLGN-1. This is due to the removal of the N-linked glycosylation site
within insert B (Lee et al., 2010). Furthermore, splice variants in
neuroligins have been associated with autism spectrum disorder
(ASD). Speciﬁcally a NLGN-3 transcript variant (without exon 7) that
is selectively expressed in ASD cohorts is predicted to harbour a pre-
mature termination after exon 6 and results in a truncated protein
(Talebizadeh et al., 2006). The truncated NLGN-3 product may have
a regulatory role in the activity of neuroligins by attenuating the
function of the full-length isoform, impacting on the balance between
excitation and inhibition in affected neural networks. In addition,
a novel NLGN-4 isoform lacking exon 4 has been described that leads
to an in-frame exclusion of 62 amino acids. However, the function-
al signiﬁcance of removing this extracellular region of NLGN-4 is
unknown (Talebizadeh et al., 2006).
Here, we describe different major splice variants in the gene en-
coding the only predicted C. elegans neuroligin, nlg-1. The nlg-1
transcript variants, in contrast to the situation described for the
mammalian genes, involve exons encoding the intracellular domain.
In particular the major variants are predicted to encode proteins
that will lack or contain a candidate polyproline SH3 binding domain
and the homologous region in the mammalian neuroligins har-
bours the binding site for gephyrin. This is pertinent because this
kind of protein scaffolding domain has been implicated in dynamic
regulation of neuroligin dependent synaptic differentiation of in-
hibitory synapses in mammals (Soykan et al., 2014). Interestingly,
we observed dynamic expression of these nlg-1 variants during the
development of C. elegans. This suggests alternative splicing might
play a role in regulating neuroligin scaffolding during network as-
sembly of the C. elegans nervous system.
1. Results
1.1. Phylogenetic analysis of neuroligins
The predicted neuroligin protein sequences of different inver-
tebrates and mammals were used to construct a phylogenetic tree
(Fig. 1A). This analysis revealed that the C. elegans NLG-1 is closely
related to invertebrate neuroligins from Apis mellifera, Drosophila
melanogaster and Aplysia californica. The vertebrate and mamma-
lian neuroligins are evolutionarily more distant from the C. elegans
neuroligin. However, the core protein including the cholinesterase-
like domain and O-linked and N-linked glycosylation sites are
conserved betweenmammals and the nematode (Calahorro, 2014).
The coding sequences (CDS) and amino acid alignment of human
and C. elegans neuroligins showed identities of 46.83–53.61% (CDS)
and 23.97–25.50% (aas), respectively (Supplementary Table 1). The
comparison of the exon–intron boundaries of C. elegans and human
neuroligins revealed that the nlg-1 transcript contains 16 exons as
compared tomammalian neuroliginswhich have 7 (NLGN-1,NLGN-
2,NLGN-4X) or 8 (NLGN-3) exons (Fig. 1B). The predicted intracellular
region of NLG-1 is encompassed and encoded by exons 13–16. This
is in contrast to the human neuroliginswhere this region is encoded
by the ﬁnal exon of the respective neuroligin (i.e. exon 7 or 8). The
expression of human NLGN-1 and/or rat Nlgn-1 cDNAs under the
C. elegans nlg-1 promoter partially rescues abnormal sensory and
locomotory behaviours in nlg-1-deﬁcient mutants (Calahorro and
Ruiz-Rubio, 2012; Izquierdo et al., 2013). This suggests that despite
limitedaminoacid identity theheterologousexpressedprotein retains
key neuroligin function conserved betweennematode andmammal.
1.2. nlg-1 gene organization and splice variants
We catalogued themajor splice variants of transcripts that encode
NLG-1 isoforms by PCR utilizing cDNA from young adult worms
(L4 + 1) as a template. We designed primers covering blocks of exons
within the nlg-1 transcript to amplify short sequences (between 0.5
and 1.2 kb), which encompassed contiguous sequences encoding the
entire cDNA length. We ﬁrst investigated the ill-deﬁned 5′ end of
the cDNA by amplifying the 5′ end of the gene. This made use of a
sense primer for SL-1 combined with an antisense primer from exon
5 that ampliﬁed a 682 base pair fragment. In contrast performing
the same PCR in which the SL-1 primer was replaced with SL-2
primer failed to amplify a product. This SL-1 ampliﬁed product was
extracted from the gel and subjected to sequencing (Fig. 2Ai). Se-
quencing this major ampliﬁcation product conﬁrmed the extension
of exon 1 by the presence of untranslated sequence encoded by a
71 nt extension from the predicted start AUG (accession: KP331805).
There was no heterogeneity in the three clones that were se-
quenced and the lower ghost band was an unspeciﬁc product
corresponding to another SL-1 trans-spliced gene (data not shown).
Thus, the nature of the ampliﬁcation and the sequencing suggests
little evidence for alternative splicing between exon 1 and exon 5
of the SL-1 trans spliced neuroligin gene (Fig. 2Ai).
The PCR ampliﬁcation for the second transcript block encoded
between exon 6 and exon 11 identiﬁed a single major band 1115 bp.
Sequences from this PCR identiﬁed that the ampliﬁcations were as
would be predicted from the routine splicing of exons 6–11. This
shows that the nlg-1 cDNA encoding the central region of the ace-
tylcholinesterase domain does not undergo alternative splicing
(Fig. 2Aii). There was no heterogeneity in the three clones that were
ampliﬁed and sequenced.
Finally, the ampliﬁcation of the 3′ end of the gene with primers
from exons 11 and 16 generated a complex set of products. Al-
though a 593 bp band that deﬁnes this region of the cDNA when
encoded by all predicted exons was identiﬁed, the major ampliﬁ-
cation product was at 455 bp. The sequence analysis of the distinct
cDNAs ampliﬁed in this PCR revealed the variation was generated
from three alternative splice variants (Fig. 2Aiii), and twominor but
detectable ampliﬁcations encoded by sequences unrelated to the
nlg-1 cDNA (Fig. 2Aiii asterisked and data not shown). This region
coded by exons 11–16 encompasses the transmembrane and in-
tracellular domains in the NLG-1 protein. Of the nlg-1 related
ampliﬁcations, the dominant band corresponded to a variant in
which exon 14 is alternatively skipped (accession: KP331806). Above
this band we identiﬁed a cDNA that contained all of the predicted
exons but this transcript contained a 5 nt sequence corresponding
to an isoform in the NCBI database (NM_001270297) (accession:
KP331808). In this isoform, the 5 nt sequence AACAG encodes a Glu
and Gln residues while in the isoform containing the 5 nt se-
quence CACGT the residues encoded are Ala and Arg (Fig. 2Aiii).
Finally below the major band, that lacks exon 14, we identiﬁed a
variant in which both exons 13 and 14 were alternatively skipped
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(accession: KP331807) (Fig. 2Aiii). Importantly the putative protein
sequences translated from these three variants remained in frame
and predicted three distinct nlg-1 transcripts encoding variant in-
tracellular domains of decreasing length which all retained the
C-terminal PDZ motif (Fig. 2B).
1.3. Differential expression of nlg-1 during C. elegans development
To analyze nlg-1 expression during development, we com-
pared two different transgenic transcriptional reporters carrying
GFP under the control of predicted nlg-1 promoters. The promoter
for the BC13535 strain consists of approximately 2 kb of nlg-1
upstream sequence whilst for the RM3071 strain it consists of
approximately 3.5 kb of nlg-1 upstream sequence, including con-
served putative regulatory sequences in the ﬁrst two nlg-1 introns
(Hunter et al., 2010) (see Section 3). For both reporter strains the
transcriptional reporter contained the putative promoter up-
stream of sequence encoding gfp. We used the strain BC13535 to
study the developmental expression and compared the expres-
sion pattern with that observed in RM3071 strain (Hunter et al.,
2010). We did not observe differences between the transgenic
strains. In both, we found nlg-1 selectively expressed in neurons
in the head ganglia and ventral nerve cord in both adult and
developing C. elegans.
Fig. 1. Evolution and exonic organization of neuroligins. (A) Phylogenetic tree of neurexins and neuroligins. The molecular phylogeny of neuroligins are displayed: the full-
length amino acid sequence of C. elegans neuroligin compared to invertebrate (Apis mellifera, Drosophila melanogaster, and Aplysia californica), vertebrate (Danio rerio) and
mammalian (Rattus novergicus and Homo sapiens) neuroligins. After alignment ambiguous regions were removed using Gblocks (V0.91b), the phylogenetic tree was recon-
structed using the maximum likelihood method implemented in the PhyML program. Graphical representation and edition of the phylogenetic tree were performed with
DrawTree (Dereeper et al., 2008). (B) Gene organization of C. elegans nlg-1 gene compared to the human NLGN genes based on the sequence entry (NCBI-GeneBank and
Ensembl): NLGN-1 (GQ489206.1), NLGN-2 (NM020795.2), NLGN-3 (GQ489207.1), NLGN-4 (BC034018.1), showing the exon–intron boundaries. The exon numbers are indi-
cated below each exon.
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Fig. 2. nlg-1 splice variants and NLG-1 isoforms. A nlg-1 splice variants. PCR using the indicated primers (half arrows) were used to amplify regions of the nlg-1 gene from
young adult (L4 +1) cDNA (Ai; Aii and Aiii). These nlg-1 ampliﬁcations were resolved on agarose gels and the molecular size (bp) of molecular weight markers indicated on
the left. Those major bands extracted from the gels and subjected to sequencing are indicated by arrow lines or asterisks. These excised cDNAs were investigated by se-
quencing. The chromatograms to the right (Ai) evidence the SL-1 splicing in the 5′ end of the gene and (Aiii) the splice variants obtained from ampliﬁcations designed to
resolve the 3′ end of the gene. This sequencing identiﬁed a 5 nt sequence-variant in exon 14 (highlighted in red capital letters). Boxes and chevrons represent exonic and
intronic sequences, respectively. The grey boxes represent untranslated sequences that are 3′ of the ampliﬁed cDNAs and are predicted from the C. elegans database. The
arrows indicate the primers position within transcripts. The asterisks denote nonspeciﬁc product found. (B) Translated NLG-1 isoforms. The translated amino acid se-
quences of the relevant splice variants are indicated in context the whole gene (upper) depicted as exons (boxes) and introns (chevrons). The amino acid sequence shows
the predicted protein sequences that arise from these splice variants relative to the transmembrane domain and the C-terminal PDZ ligand (bold) The translation of cDNA
sequences was performed using the EMBOSS Transeq (EMBL-EBI) program.
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To resolve the temporal expression during development wemoni-
tored expression against the three developmental periods when
C. elegans neurons are generated. The ﬁrst is during the prolifera-
tion phase of embryogenesis, the second at the late-L1 stage, and
the third at the L2 stage (Sulston and Horvitz, 1977; Sulston et al.,
1983). We found that nlg-1 is expressed early in the development
of C. elegans, observing neuroligin expressing cells in the comma
stage of the embryo when neurogenesis is beginning. This initial
expression is sustained during the ﬁrst phase of embryogenesis in
neurons in the head ganglia (Fig. 3A) and is clearly present in ventral
nerve cord neurons during the proliferation phases in L1 and L2
stages (Fig. 3A). The expression in L4 and adult stages was marked
by ﬂuorescence in the head region and ventral cord and is consis-
tent with nlg-1 contributing its function during later development.
Based on this complex expression of nlg-1 during early and late
development we investigated the relative expression of the splice
Fig. 3. Dynamic expression of nlg-1 splices variants during development. (A) nlg-1 expression during development. Animals carrying the Pnlg-1::GFP transgene were imaged
at ×65 and ×100 times magniﬁcations. We observed nlg-1 promoter drive GFP expression from 1.5-fold stage into the adult. Key stages of embryonic and larval develop-
ment of C. elegans are indicated on the top. For the embryonic development, samples were imaged by DIC and epiﬂuorescence, respectively. The asterisks indicate auto-
ﬂuorescence in gut cells, and yellow arrowheads indicate GFP expressing cells. For the larval development cartoon of the distinct stages overlie panels showing epiﬂuorescence
images of the whole worm (upper), head region middle panel or orientated to highlight the ventral cord (lower panel) at distinct stages and magniﬁcation. The scale bars
always correspond to 10 μm. (B) Differential expression of ngl-1 splice variants during C. elegans development. PCR was performed on cDNA generated from the indicated
mixed or staged developmental window. During stages L1–L2 and L3 the dominant isoform corresponds to transcripts containing exon 14. However, in embryo and stages
L4-adult the major neuroligin isoform corresponded to transcripts lacking exon 14. act-2 gene was used as control gene and showed relatively equivalent expression.
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variants we initially identiﬁed in the young adult cDNA. For these
experiments mRNA frommixed and developmentally staged popu-
lations of C. eleganswere subjected to reverse transcription and PCR
ampliﬁcation. This was done under conditions that successfully am-
pliﬁed cDNAs harbouring variants of the intracellular domain of nlg-1
(Fig. 2Aiii). Based on comparison to the products generated from
parallel PCRs from young adults, there were clear shifts in the pro-
portion of the distinct ampliﬁcations. These changes were observed
against a consistent ampliﬁcation of act-2, which was used as an
internal control (Fig. 3B). In the mixed stage mRNA, extracted from
a plate containing eggs and all subsequent stages of development,
the proportion of ampliﬁcations suggest relatively equivalent ex-
pression of the two isoforms. Based on size these are encoded by
the 593 bp variant containing all sequences encoded by exons 11–15
(Fig. 3B NLG-1 full length) and the 455 bp variant lacking exon 14
NLG-1 (Fig. 3B Δ#14). In addition there was a low but consistent
expression of a product with a size consistent with the variant NLG-1
Δ#13–14 (350 bp). When this analysis was extended to mRNA ex-
tracted from staged populations the ampliﬁcations suggested a
dynamic regulation of the major nlg-1 transcripts. In particular the
455 bp product encoding the NLG-1 Δ#14 was selectively ex-
pressed in the embryo, late larval and adult stages. This coincided
with a reduced expression of the 593 bp full length variant. In con-
trast, those larval stages (L1–L2 and L3) that expressed low levels
of the NLG-1 Δ#14 variant exhibited high levels of expression of
cDNA containing all of the potential exons predicted for this region
of the nlg-1 gene.
1.4. Exon 14 within the nlg-1 transcript contains a putative
polyproline SH3 binding domain
The dynamic regulation of nlg-1 expression, and in particular of
the splice variants, suggests they impart a functional signiﬁcance.
The sequence encoded by exon 14 predicts a polyproline se-
quence that would be present or absent in the two variants that are
differentially expressed during development. These sequences predict
a Src-Homology 3 (SH3) binding domain containing the following
amino acid sequence: SPLSLMPPPPPPLNG (Supplementary Fig. S2).
SH3 domain containing proteins provides a route for selective re-
cruitment of intracellular proteins as they mediate protein–protein
interactionswith SH3-bindingdomains required for scaffoldingof sig-
nallingnetworks. Indeed, theproline-rich regions are the secondmost
commonsequencemotif currently identiﬁed in theC. elegans genome
(Rubin et al., 2000). Thus the identiﬁed pattern of splicing in the in-
tracellular domain of nlg-1 indicates this gene will express proteins
that include or omit the SH3 binding domain. In addition, this region
of mammalian neuroligins encoded by exon 14 harbours a distinct
stretch that acts as an independent binding site for the scaffoldprotein
gephyrin. This further implies that the amino acids encoded by exon
14 are well placed to modulate NLG-1’s scaffolding function.
2. Discussion
Neuroligin is a synapse adhesion molecule that plays an essen-
tial role in assembly and recruitment of synaptic scaffolds and is
pivotal to the correct function and development of the synapses
(Yamagata et al., 2003). Although the gene organization of neuroligins
is not conserved between C. elegans andmammals the overall domain
architecture is well conserved (Fig. 1A) (Calahorro, 2014; Calahorro
and Ruiz-Rubio, 2012). There is only one C. elegans neuroligin while
there are 4 or 5 separate genes in mammals and human respec-
tively (Fig. 1B). The exon–intron boundaries in the C. elegans and
human neuroligin transcripts are different. The C. elegans nlg-1 gene
presents more exons; this neuroligin gene organization suggests a
tendency towards exon reduction between invertebrates and
mammals. However, the numbers of residues in the neuroligin
proteins are relatively conserved (847 aa in NLG-1; 863 aa in
NLGN-1; 835 aa in NLGN-2; 848 aa in NLGN-3; 816 aa in NLGN-4).
The observation that partial rescue of behavioural deﬁcits in C. elegans
can be achieved by heterologous expression of mammalian
neuroligin supports some level of functional conservation across the
phyla (Calahorro and Ruiz-Rubio, 2012; Izquierdo et al., 2013).
The description of splicing in themammalian neuroligins is con-
ﬁned to variants from regions encompassed by the extracellular
domains (Koehnkeet al., 2008, 2010). The current analysis of C. elegans
NLG-1 suggests splicing events are restricted to the 3′ end of the gene
encoding the intracellular domain.We found threemajor splice vari-
ants associated with skipping of exon 14 alone, or exons 13 and 14
in combination (Fig. 2). This ismuch lower diversity than the 24 pre-
dicted splice variants previously suggested forC. elegans nlg-1 (Hunter
et al., 2010). We cannot rule out further minor variants will emerge
thatmightbe revealedbydeep sequencingordistinct PCRapproaches.
The identiﬁed splicing for NLG-1 appears restricted to the in-
tracellular domain in C. elegans and this may have repercussions for
the way in which the proteins encoded by the splice variants reg-
ulate synaptic function. A number of candidate neuroligin scaffold
proteins have been described and many of these are mediated by
PDZ binding domains, a motif that is conserved in all of the C. elegans
neuroligin isoforms we identiﬁed (Figs. 3 and 4). In addition, the
intracellular domains of neuroligins recruit scaffold proteins through
non-PDZ domain interactions (Dinamarca et al., 2011; Irie et al., 1997;
Poulopoulos et al., 2009). The importance of the intracellular domain
of mammalian neuroligins in selectively scaffolding excitatory and
inhibitory synapse is clear (Craig and Kang, 2007; Dean and Dresbach,
2006; Li et al., 2007; Rao et al., 2000). In the mammalian nervous
system distinct neuroligins undergo speciﬁc protein interactions with
glutamate and GABA receptor containing scaffolds that help deﬁne
major neuronal classes (Budreck and Scheiffele, 2007; Graf et al.,
2004; Siddiqui et al., 2010; Song et al., 1999; Varoqueaux et al., 2004).
Interestingly, themajorvariant encodedby thepresenceor absence
of exon 14 is from an equivalent part of the mammalian gene that
encodesabindingsite for thescaffoldproteingephyrin (Supplementary
Fig. S2). In addition, a distinct sequence found in the 5′ end of exon
14encodesapolyprolineSH3bindingdomain thatwill lieN-terminally
to the sequence that encodes the gephyrin binding domain inmam-
malian neuroligins. Juxtaposition of an SH3 binding domain and
gephyrinbinding regionhasbeen functionally dissected in the context
of mammalian NLGN-2. Here, the neuroligin acts to directly recruit
gephyrin and, by association, bound collybistin. The latter harbours
a Dbl domain which has an intrinsic guanine nucleotide exchange
factor activity (GEF). This activity is otherwise inhibited by an intra-
molecular interactionwithanNterminal inhibitorySH3domain found
in most collybistin splice variants (Mayer et al., 2013; Soykan et al.,
2014). This inhibition is released by ancillary binding to polyproline
containing proteins, which, in the case of the gephyrin recruited
collybistin, can be encoded by the SH3 binding domain that is se-
lectively expressedby theNLGN-2 intracellular domain (Soykan et al.,
2014). This co-ordinated gephyrin binding and collybistin activation
mediatesmaturation of overlying inhibitory synapses (Papadopoulos
and Soykan, 2011; Soykan et al., 2014). In this scenario dual recruit-
ment and activation is achieved by distinct protein interactionmotifs
singularly encoded by the neuroligin (Levinson et al., 2010; Shipman
et al., 2011). Interestingly, the sequence encoded by the presence or
absence of exon-14 of the C. elegans nlg-1 has the potential to endow
or remove this potential.
Thus, conceptually the splicing identiﬁed for C. elegans nlg-1 in
exon 14 implicates the expression of distinct neuroligin isoforms,
generated from a single gene, with signatures that might dynam-
ically regulate scaffolding. Despite the low overall amino acid identity
the strongest homology in the intracellular domain of C. elegans nlg-1
is within the identiﬁed mammalian gephyrin binding domain. The
3′ end of exon 14 encodes 10 (PDYTLTLRRS) of the 16 amino acids
74 F. Calahorro et al./Gene Expression Patterns 17 (2015) 69–78
(Fig. 4A) that recruit gephyrin (Fig 4). However, whether this serves
as a conserved recruitment platform for moc-1, lin-46 and moc-2,
the C. elegans genes with most homology to gephyrin would need
to be tested (Pepper et al., 2004). Most of the key determinants in
nlg-1 or the gephyrin orthologues are present but too limited tomake
predictions based on sequence homology alone (Pepper et al., 2004).
Similarly, whether the polyproline motif encoded in the
neuroligins that retain exon 14 containing transcripts switches on
a collybistin like GEF activity is diﬃcult to predict. The C. elegans
genome does not predict a direct homologue of collybistin. However,
UNC-73 and SOS-1 have similar domain organizations to collybistin,
as they are encompassed by an N-terminal SH3 domain followed
Fig. 4. Hypothetical model of NLG-1 Δ#14 isoform. (A) Partial alignment of C. elegans and human neuroligins intracellular domains. Blue box: C. elegans exon 13, orange
box: C. elegans exon 14. TM: transmembrane domain, PDZ: PDZ domain. The black and grey boxes indicate identical and conserved residues respectively. ‘*’: identical; ‘:’:
conserved substitutions; semi-conserved substitutions. (B) Gene splicing and the regulation of nlg-1 scaffolding potential modulates function during development. The pu-
tative SH3 binding domain, within exon 14, could act as a modulator of synaptic protein recruitment. The extracellular domain represented in the cartoon corresponds to
predictive 3D model of C. elegans NLG-1 protein (Swiss-Model Proteomic Serve) based on the crystal structures of mammalian neuroligins. The cartoon indicates that the
retention or loss of exon 14 will selectively promote the assembly and disassembly of neuroligin containing adhesion junctions at distinct stages of neuronal development.
In the context of the postsynaptic specialization this model indicates selective recruitment of binding partners through an SH3 domain interaction. Previous studies with
mammalian neuroligins indicate determinants predicted to be encoded in exon 14 (SH3 binding domain or the gephyrin binding domain) modulate scaffold composition.
Thus directly binding to the SH3 domain of GTPase exchange factor collybistin’s both recruits and activates it. Further the adjacent gephyrin binding domain ensures prox-
imal cross talk to this receptor-clustering molecule. These neuroligin mediated interactions impact on synaptic differentiation reinforcing the potential role that splicing of
exon 14 may play during C. elegans development.
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by a tandem Dbl-1 guanine nucleotide exchange factor (GNEF) and
membrane binding Pleckstrin homology (PH) domain (Modzelewska
et al., 2007). The activity of the GEF domains of these proteins maybe
controlled by SH3 auto inhibition and they have been implicated
in synaptic structure and function (Marcus-Gueret et al., 2012).
However, there is no evidence that this is controlled by mutual in-
teraction with nlg-1. Direct investigations will be needed to probe
this possibility.
Investigation of neuroligins in the mammalian nervous system
has tended to focus on a predominant role in late synaptogenesis
(Brose, 1999; Washbourne et al., 2004) when nascent synapses are
stabilized. Our results indicate that neuroligin is expressed in the
pre comma stage of the C. elegans embryo. By the time of hatching
the majority of the nematode’s neurons have been born (Altun and
Hall, 2014). This may mean that nlg-1 contributes to early
neurodevelopmental events that occur before hatching. This early
embryonic expression is sustainedacross themajor phases of synapse
formation through L1–L2 and L4. During L1–L2 neurogenesis the
interneurons are born and there is rewiring in the motor nervous
system (Altun and Hall, 2014). Thus, the developmental expression
of the nlg-1 gene in C. elegans is consistent with a contribution to
all the important programs in which there is synapse stabilization
and scaffolding to produce signalling networks at mature syn-
apses. In this sense, the presence of exon 14 during L1–L3 stages
could provide a binding site for different scaffolding proteins, in-
dicating that the activity for recruiting and binding by NLG-1 in the
postsynaptic density is high. In contrast, in L4 and adult stages the
presence of exon 14 would not be necessary since the synapses are
stabilized. Finally, in all C. elegans developmental stages there is a
co-existence of full lengthNLG-1 and the splice variant NLG-1 Δ#14.
This indicates that thebalanceof expressionof distinctNLG-1 isoforms
could underpin the generation of different postsynaptic identities.
This study indicates how the dynamic splicing of a single gene in
C. elegans nervous system might allow something of the synaptic
diversity that the vertebrate neuroligins achieve through segregat-
ing function to distinctmembers of amultiple gene family (Chubykin
et al., 2007; Levinson and El-Husseini, 2005;Mackowiak et al., 2014).
3. Materials and methods
3.1. Nematodes
The nematode strain (Bristol N2) used in this work was provid-
ed by the Caenorhabditis Genetics Center, and was grown on
Escherichia Coli strain OP50. To obtain synchronized animals, gravid-
adult worms were put on a plate with OP50 bacteria and left to lay
eggs for 5 hours. Adults were removed and eggs were incubated at
20 °C for increasing times over 20 hours (L1–L2), 30 hours (L3), 38
hours (L4) and 48 hours (adult) to obtain plates with populations
containing indicated developmental stages. To harvest embryos
gravid-adults were suspended in 2–4 weight/volume of hypochlo-
rite solution and gently shaken for 5 min to dissolve the worm and
release the embryos. The isolated embryos were extensively washed
with M9 buffer to remove the hypochlorite solution. To generate
mixed stage populations 15–20 adult worms were put on a seeded
6 cm plates and maintained for 4 days at 20 °C.
nlg-1expressionwas investigatedusingtransgenicstrains:BC13535,
dpy-5(e907)/pdt-5(e907); sIs13247 [rCes C40C9.5::GFP + pCeh361];
RM371,pha-1(e2123); sIs [Pnlg-1::YFP + pCI(pha-1)]. TheRM371strain
was a kind gift from James Rand (Hunter et al., 2010).
3.2. Microscopy
Animals were mounted in a 5 μl drop of 10 mM levamisole
(Sigma) and paralyzed on a 2% agarose pad covered with 24 × 24mm
coverslip. After 15 minutes differential interference contrast (DIC)
and ﬂuorescence imaging were performed on a Nikon Eclipse (E800)
and Zeiss Axiovert 200 microscopes. Equal adjustment of bright-
ness and contrast on images was done using Adobe Photoshop
Software (Adobe Systems) and ImageJ (NIH).
3.3. In silico tools
Primer design for the oligonucleotide used tomap splice variants
was performedusing theOligo 6 program. DNA sequenceswere ana-
lyzedusingChromas,ClustalW2(EMBL-EBI) (Goujonetal., 2010;Larkin
et al., 2007;McWilliametal., 2013), BLAST (NCBI) andEnsembl (EMBL-
EBI,WelcomeTrustSanger Institute). Individual sequenceswerealigned
tocorrespondingsequencesavailable inWormbase (Wormbaseversion
WS244) and GeneBank (NCBI), in order to check for missing exons.
Phylogenetic analyses were performed using phylogeny.fr (LIRMM-
cnrs) (AnisimovaandGascuel, 2006;Castresana, 2000;Chevenet et al.,
2006; Dereeper et al., 2008; Edgar, 2004; Guindon et al., 2010). Hy-
pothetical protein models were performed using UniProtKB/Swiss-
Prot (Swiss-Model Proteomic Serve) (Arnold et al., 2006; Biasini et al.,
2014; Bordoli et al., 2009; Guex and Peitsch, 1997).
3.4. mRNA and cDNA template preparation
Total RNA from about 50 mg of pooled sample of mixed stage or
individual stages was prepared using TRIZOL Reagent (Invitrogen
Life Technologies). The quality and quantity of mRNAwas assessed
using a Nanodrop Spectrophotometer (Thermo Scientiﬁc) and elec-
trophoresis. All RNAsamplesobtained fromthedifferentdevelopment
stages exhibited an A260:A280 ratio close to 2.0 and exhibited a 28S
and 18S ratio of 2:1 of rRNA, measured by electrophoresis.
All isolated RNAs were precipitated in 70% ethanol and stored
at −80 °C. Before use, the RNA was suspended in RNase, DNase-
free molecular water (cat#W4502, Sigma-Aldrich).
First strand cDNA was prepared from 1 μg of total RNA using
oligo(dT) primers with SuperScript II/III-Reverse Transcriptase
(cat#18080-093, Invitrogen Life Technologies).
3.5. Sequences
The following CDSs (coding sequences) and their respective
protein sequences were used: human NLGN-1 (GQ489206.1), human
NLGN-2 (NM_020795.2), humanNLGN-3 (GQ489207.1), humanNLGN-
4X (BC034018.1), human NLGN-4Y (BC113551.1), Mus musculus
Nlgn1 (AAH98461.1), Mus musculus Nlgn2 (EDL12455.1), Mus mus-
culus Nlgn3 (AAI50774.1), Rattus norvegicus Nlgn1 (NP_446320.1),
Rattus norvegicus Nlgn1 (AAA97870.1), Rattus norvegicus Nlgn3
(AAA97871.1), Danio rerio nlgn1 (NP_001135737.1), Danio rerio nlgn2
(NP_001159808.1), Danio rerio nlgn3 (NP_001159804.1), Danio rerio
nlgn4 (NP_001159809.1), Apis mellifera NLG1 (ACM48186.1), Apis
mellifera NLG2 (ACM48190.1), Apis mellifera NLG3 (NP_001139208.1),
Apis mellifera NLG4 (NP_001139209.1), Apis mellifera NLG5
(NP_001139211.1), Drosophila melanogaster DNlg1 (AFH06285.1),
Drosophila melanogaster DNlg2 (NP_001285693.1), Drosophila
melanogaster DNlg4 (AHN57419.1), Aplysia californica nlgn1
(ADK54931.1), C. elegans nlg-1 (NM_001270297.1).
3.6. SL (splice leader) analysis
SL primers were designed according to the published sequences
for SL-1 (splice leader-1) 5′-GGTTTA ATTACCCAAGTTTGAG-3′ and SL-2
(splice leader-2) 5′-GGTTTTAACCCAGTTACTCAAG-3′, respectively.
These were combined in a standard PCR reaction with the primer
5′NLG1(exon5) 5′-CTATTACCAGAGCAAGACGATG-3′. 5′NLG1(exon3)
5′-AATGCAGACTGGAGAAACTTTG-3′ primer was used to sequence
the SL-1/SL-2 and exon5 PCR product. All PCRswere performed under
standard conditions (Phusion High-Fidelity DNA polymerase,
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Thermo). Brieﬂy, the PCR reactions were performed as follows in a
total volume of 50 μl: 0.5 μl of 2 U/μl Phusion DNA polymerase, 3 μl
of 5 μM each primer, 4 μl of 2.5 mM dNTPs, 10 μl 5X Phusion GC
buffer, and 2 μl of cDNA template. Then assembled PCR samples were
mixed thoroughly by pipetting and then run in a thermocycler with
the following program: 98 °C for 30 s, and then a loop of the fol-
lowing for 35 cycles: 98 °C for 10 s, Tm °C for each primers (described
in the below section) for 30 s, 72 °C for 30 s per kb. One last ex-
tension was performed at 72 °C for 10 minutes.
The ampliﬁed products were resolved on a 0.7% agarose gel and
individual bands were recovered using a QIAquick Gel Extraction
Kit (Quiagen) according to manufacturer’s instructions. The puri-
ﬁed PCR products were directly sequenced using conventional
techniques (Euroﬁns, NWG-operon). The ampliﬁcation product was
sequenced using primer used in PCR and additional primer de-
signed against internal sequences from exon 3, 5′NLG1(exon3)
5′-AATGCAGACTGGAGAAACTTTG -3′.
3.7. Systematic splices variants analysis
Mixed or speciﬁcally staged cDNA were used as a template in
standard PCR reactions designed to amplify distinct blocks from the
predicted nlg-1 cDNA sequence (see section discussed earlier for PCR
reaction details using Phusion High-Fidelity DNA polymerase).
Primers were designed to amplify selective regions encoded by exons
1–5 (encompassing SL-1), 6–11 and 11–16 respectively, covering
distinct but overlapping sequences from the full-length nlg-1 cDNAs.
The sizes of the amplicons were between 0.5 and 1.2 kb in which
the start is encoded by exon 1 and the stop by exon 16. Each block
was ampliﬁed from at least three independent PCRs (Fig. 2A).
The primers used to amplify these 3 blocks were as follows: SL-1
(splice leader-1) 5′-GGTTTAATTACCCAAGTTTGAG-3′ and 5′NLG-
(exon5) 5′-CTATTACCAGAGCAAGACGATG-3′ to amplify the ﬁrst block
that contain 682 bp (Tm 58 °C); ngl-1 (exon 6) forward 5′-
GCTTCTCTGGTTTCTCTTCTTATG-3′ and nlg-1 (exon 11) reverse 5′-
CTGTTTCCTTTCCATTCTTGTGC-3′ to amplify the second block that
contain 1115 bp (Tm 56 °C); nlg-1 (exon 11) forward 5′-
AGAATGGAAAGGAAACAGAGCC-3′ and nlg-1 (exon 15) reverse 5′-
GTGCGATGCGGATAGTAAGGG-3′ to amplify the third block that
contain 593 bp (Tm 60 °C).
4. Conclusions
Isolating major splice variants indicates that the extracellular
domain of C. elegans neuroligin is not spliced in any signiﬁcant way.
In contrast, three experimentally deﬁned variants suggest that the
intracellular domain is spliced and predicts a polyproline se-
quence. This may allow for differential interactions with SH3 domain
binding partners with potential to impart developmentally regu-
lated neuroligin dependent scaffolding.
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